Clinical Trials Browser

Phase 2 × Lymphoma, Follicular × Interleukin-2 × Clear all

NCT00100737 2006-02-06

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)

Phase 2 Terminated

Lymphoma, Follicular, Lymphoma, Non-Hodgkin